Concurrent change in dehydroepiandrosterone sulfate and functional performance in the oldest old: results from the Cardiovascular Health Study All Stars study.
BACKGROUND
The correlation between dehydroepiandrosterone sulfate (DHEAS) decline and age led to the hypothesis that DHEAS might be a marker of primary aging, though conflicting data from observational studies of mortality do not support this. We evaluated concurrent DHEAS and functional decline in a very old cohort to test if DHEAS change tracks with functional change during aging.


METHODS
DHEAS and functional performance (gait speed, grip strength, Modified Mini-Mental State Examination [3MSE] score, and digit symbol substitution test [DSST] score) were measured in 1996-1997 and 2005-2006 in 989 participants in the Cardiovascular Health Study All Stars study (mean age 85.2 years in 2005-2006, 63.5% women and 16.5% African American). We used multivariable linear regression to test the association of DHEAS decline with functional decline.


RESULTS
After adjustment, each standard deviation decrease in DHEAS was associated with greater declines in gait speed (0.12 m/s, p = .01), grip strength (0.09 kg, p = .03), 3MSE score (0.13 points, p < .001), and DSST score (0.14 points, p = .001) in women only. Additional adjustment for baseline DHEAS attenuated the association with grip strength but did not alter other estimates appreciably, and baseline DHEAS was unassociated with functional decline.


CONCLUSIONS
In this cohort of very old individuals, DHEAS decline tracked with declines in gait speed, 3MSE score, and DSST score, but not grip strength, in women independent of baseline DHEAS level. DHEAS decline might be a marker for age-associated performance decline, but its relevance is specific to women.
Sanders
J L
JL
Medical Scientist Training Program, School of Medicine, University of Pittsburgh, Pennsylvania, USA. sanders.jason@medstudent.pitt.edu
Cappola
A R
AR
Arnold
A M
AM
Boudreau
R M
RM
Chaves
P H
PH
Robbins
J
J
Cushman
M
M
Newman
A B
AB
D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D003071:Cognition; D015331:Cohort Studies; D019314:Dehydroepiandrosterone Sulfate / Q000097:blood*; D005260:Female; D005684:Gait; D015577:Geriatric Assessment; D018737:Hand Strength; D006306:Health Surveys; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D009483:Neuropsychological Tests; D012737:Sex Factors; D014481:United States
D015415:Biomarkers; D019314:Dehydroepiandrosterone Sulfate
Ann N Y Acad Sci. 1995 Dec 29;774:143-8
8597454
Front Neuroendocrinol. 2009 Jan;30(1):65-91
19063914
Ann Epidemiol. 1995 Jul;5(4):270-7
8520708
Ann N Y Acad Sci. 1995 Dec 29;774:121-7
8597452
J Clin Endocrinol Metab. 1984 Sep;59(3):551-5
6235241
J Am Geriatr Soc. 2009 Mar;57(3):432-40
19187412
Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):377-85
16101547
Arch Intern Med. 2000 Jun 26;160(12):1761-8
10871968
N Engl J Med. 2006 Oct 19;355(16):1647-59
17050889
J Gerontol. 1978 Mar;33(2):232-8
637915
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13410-5
8917605
Exp Gerontol. 2007 Oct;42(10):979-87
17604586
Aging (Milano). 1999 Feb;11(1):30-4
10337439
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):8145-50
11427700
J Clin Endocrinol Metab. 2001 Sep;86(9):4171-7
11549645
N Engl J Med. 1986 Dec 11;315(24):1519-24
2946952
Ann Epidemiol. 1991 Feb;1(3):263-76
1669507
N Engl J Med. 1987 Sep 10;317(11):711
2957589
J Clin Psychol. 1986 Jan;42(1):28-33
3950011
Neuroepidemiology. 2005;24(1-2):8-14
15459503
J Gerontol A Biol Sci Med Sci. 2007 Aug;62(8):844-50
17702875
Diabetes Care. 1997 Jul;20(7):1183-97
9203460
J Gerontol A Biol Sci Med Sci. 2006 Sep;61(9):957-62
16960027
Clin Chem. 1995 Feb;41(2):264-70
7874780
J Gerontol A Biol Sci Med Sci. 2009 Dec;64(12):1268-74
19713299
Ann Epidemiol. 1993 Jul;3(4):358-66
8275211
Int J Androl. 2008 Feb;31(1):50-9
18190426
J Am Geriatr Soc. 1994 Apr;42(4):420-3
8144828
Ageing Res Rev. 2008 Jul;7(3):225-33
18672097
Ageing Res Rev. 2009 Jan;8(1):18-30
18692159
J Clin Psychiatry. 1987 Aug;48(8):314-8
3611032